Altre lingue Mithra Pharmaceuticals S.A.

Azioni

Mercato chiuso - Euronext Bruxelles Altri mercati azionari 17:35:26 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,216 ^EUR	-1,82%		-3,57%	-82,78%

08/03	Mithra Pharmaceuticals SA riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
05/03	Mithra Pharmaceuticals avvierà un processo di monetizzazione che comporterà la vendita di attività e di un'impresa	MT

Mithra Pharmaceuticals Obtains Court Protection Measures	22/04
Mithra krijgt steun van rechtbank tegen schuldeisers	22/04
Mithra secures court protection measures to advance monetization process	22/04
Early data from Mithra's ESTELLE pediatric study to be presented at two upcoming congresses	17/04
Mithra bereikt mijlpaal in onderzoek naar estetrol	09/04
Mithra Pharmaceuticals S A : reaches milestone in estetrol skin study	08/04
Noodlijdend Mithra stelt jaarverslag uit	28/03
KBC Securities verlaagt koersdoel Mithra fors	08/03
Licht hogere start Brussel voorzien in aanloop naar banenrapport VS	08/03
Lagere omzet Mithra ondanks hogere productomzet	08/03
Mithra reports full year 2023 financial results	08/03
Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Mithra announces changes to its executive management	06/03
Mithra Pharmaceuticals to Initiate Monetization Process Involving Sale of Assets, Business	05/03
Mithra Pharmaceuticals Terminates CEO; Names CFO, COO as Successors	05/03
Mithra zet zichzelf in de etalage	05/03
Mithra announces changes to its executive management	05/03
Mithra announces changes to its executive management	05/03
Mithra initiates monetization process, receives bridge loan from existing lenders	05/03
Mithra Pharmaceuticals SA Announces CEO Changes	05/03

Non ci sono risultati per questa ricerca